INBS INTELLIGENT BIO SOLUTIONS INC.

$2.30 +0.88%

Healthcare · Surgical & Medical Instruments & Apparatus

INTELLIGENT BIO SOLUTIONS INC. (INBS) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $6 million. Shares last traded at $2.30, 93.2% below their 52-week high. Over the past year the stock is up 20.4%. Net profit margin is -346.2%, below the peer median of -7.6%. Revenue declined 1.9% year over year.

Market Cap

$6M

Shares Out

2.4M

EPS (TTM)

$-30.08

P/E Ratio

—

P/S Ratio

1.80

P/B Ratio

0.61

Dividend / Share

—

Dividend Yield

—

52-Week High

$33.81

52-Week Low

$0.55

Volume

3,003

Avg Vol (3m)

2,638.063

Performance

-3.77%

-29.56%

-32.94%

-57.01%

YTD

-71.25%

+20.42%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

40.73

SMA (50)

$2.66

SMA (200)

$3.53

Price vs SMA50

-13.56%

Price vs SMA200

-34.77%

ATR (14)

$0.20

Financials

Revenue

$3M

Net Income

$-11M

Gross Margin

40.8%

Operating Margin

-348.7%

Net Margin

-346.2%

Return on Equity

-117.9%

Return on Assets

-71.1%

Current Ratio

2.11

Debt / Equity

0.18

Revenue Growth (YoY)

-1.9%

Latest reported annual period ending 2025-06-30 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q3 2026	$-7.54	2026-05-13
Q2 2026	$-6.27	2026-02-12
Q1 2026	$-0.35	2025-11-12
FY 2025	$-2.00	2025-08-15
Q3 2026	$-15.92	2026-05-13
Q2 2026	$-11.82	2026-02-12

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

INBS vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

1.80 / 2.52 med

-28% discount

Net margin vs peers

-346.2% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.